News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC
Photo of Saul Priceman from Caryn Lerman/LinkedIn
Jun 15, 2024, 07:37

Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC

Saul Priceman, Associate Professor at City of Hope, made the following post on X:

“Proud of our work published today in Nature Medicine, sharing results from our phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC. Big collaborations work Tanya Dorff, Stephen Forman, Peter Kuhn, Lior Pachter! Thank you Prostate Cancer Foundation for your support!”

Read further.
Source: Saul Priceman/X

cancer City of Hope clinical trial results Lior Pachter mCRPC Nature Medicine OncoDaily Oncology Peter Kuhn Prostate Cancer Foundation prostate cancer research PSCA-CAR T cell therapy Saul Priceman Stephen Forman Tanya Dorff
Special Coverage
Blog
Feb 21, 2025, 15:06
The full press release of ELLOK is out
Blog
Feb 21, 2025, 14:59
Siobhan Freeney: What women in Ireland need to know about Dense Breasts and Cancer
Blog
Feb 21, 2025, 14:54
CEO of the Canadian Cancer Society about the inequities in cancer care across populations in Canada - UICC
Career
Feb 21, 2025, 14:34
Kristiyana Kaneva is appointed as Medical Director of Oncology Early Development at AbbVie
Blog
Feb 21, 2025, 14:27
Douglas Flora: A Cure for Cancer - Closer Than We Think?
Blog
Feb 21, 2025, 14:26
14th Biennial Childhood Leukemia and Lymphoma Symposium: Advancing Research and Collaboration in Budapest
Blog
Feb 21, 2025, 14:13
Rachel Chown: An incredibly inspiring and humbling talk from Liubov Lisovska
Science
Feb 21, 2025, 14:08
Survival improvement of patients with melanoma brain or leptomeningeal metastases in Denmark - CCIT-DK
Science
Feb 21, 2025, 13:51
Aaron Sverdlov: Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities
Blog
Feb 21, 2025, 13:40
Breaking barriers: ensuring equal cancer care access for diverse communities - SPCC
Blog
Feb 21, 2025, 13:29
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society's SABCS
Blog
Feb 21, 2025, 13:28
Targeted protein degradation is changing the landscape of cancer treatment - The ICR